Word: patently
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Other critics in the academic community and elsewhere fear exploitation of recombinant DNA research for profit. George S. Wald, Higgins Professor of Biology Emeritus, mentioned a recent court ruling allowing researchers--whether affiliated with academic institutions or industry--to patent any new micro-organisms they develop. The pharmaceutical industry in particular is conducting intensive research, and would stand to gain from any products it develops as a basis for new antibiotics. Proponents of legislation to regulate recombinant DNA cite this possibility of industry profiteering as a rationale for nationwide legislation...
Beckett even wore pointed-toe patent leather pumps that were too small because he wanted to wear the same shoe in the same size as Joyce, who was very proud of his small, neatly shod feet. Joyce had been vain about his feet since his youth, when poverty forced him to go about Dublin in a pair of white tennis shoes, the only footwear he owned. It is impossible to know if Joyce was even aware of Beckett's slavish gesture, for his eyes were so weak that he saw very little. What is intriguing about this imitative gesture...
Experimenting in secrecy has been becoming an all-too-common problem as professional jealousies and competition for limited research funds compete with the hallowed scientific method. Take, for example, news reports last month that universities can now patent certain experimental techniques, and what this will do to the principle of reproducibility of results...
...coating of gibberellic acid is by no means the first attempt at chemical golf. In 1928 Samuel J. Bens of New York City took out patent #1,664,397 on a golf ball "with chemical pockets dotting the outer skin." When the ball impacted the pockets burst, releasing a miasma of ammonium chloride. This simple method of chemical detection would definitely be a boon to the golfer traipsing his way through a snow bank in search of the elusive pill...
Smith sold his patent rights to Baxter Travenol Laboratories of Deerfield, Ill., which extracted from papain another enzyme, chymopapain, that was more potent and less toxic. Baxter Travenol trade-named its product Disease and obtained U.S. Food and Drug Administration approval in 1963 for its use as an investigational new drug for humans. In twelve years doctors treated some 15,000 patients, and reported that symptoms were relieved in most cases. Meanwhile, Baxter Travenol had applied to the FDA for approval of Disease as a prescription item for any licensed physician...